Advancing MDS Care Together
Healthcare Professionals
Access the latest research insights, and educational tools designed to enhance patient care in the field of myelodysplastic syndromes (MDS). Collaborate with peers and stay informed with the most recent advancements in MDS treatment and management.
Who is the MDS Foundation?
We are a global non-profit advocacy organization building critical awareness of Myelodysplastic Syndromes (MDS) - a rare, often undetected blood cancer. The MDS Foundation has supported patients and their families as well as healthcare providers in the fields of MDS, AML and other related cancers for over 30 years.
The MDS FoundationBecome a Member
Your membership not only provides exclusive benefits but also plays a crucial role in supporting our educational initiatives, events, research, and advocacy efforts.
Young Investigator Support
Membership is a requirement for young investigator grant applications and/or abstract applications, providing opportunities for emerging professionals to advance their research.
Free Shipping
Benefit from free shipping of educational materials, ensuring you have the resources needed to stay informed and advance your practice.
Leukemia Research Subscription Discount
Receive a discount on subscriptions to Leukemia Research, making it more affordable to stay updated on the latest research and developments.
Professional Program Discounts
Take advantage of discounts to MDSF professional programs, including congresses and symposia, enhancing your professional development at reduced rates.
Printed Newsletters
Receive printed newsletters from the MDS Foundation, keeping you informed about the latest news, research, and events in the field.
Expedited Clinical Trial Listings
Enjoy expedited listing of MDS/CHIP/CCUS/sAML clinical trials on our clinical trials platform, facilitating quicker access to crucial trial information.
Make a Difference Today
Unlock exclusive benefits, contribute to a global network of professionals, and make a lasting impact in the fight against MDS. Your expertise is a valuable addition to our community. Join now and be a driving force for positive change.
Upcoming Events
View all Events
What's New?
View all News
December 18, 2024
Syndax Announces FDA Approval of Revuforj® (revumenib), the First and Only Menin Inhibitor to Treat Adult and Pediatric Patients with Relapsed or Refractory Acute Leukemia with a KMT2A Translocation
Syndax Announces FDA Approval of Revuforj® (revumenib), the First and Only Menin Inhibitor to Treat Adult and Pediatric Patients with Relapsed or Refractory Acute Leukemia with a KMT2A Translocation
Syndax Pharmaceuticals (Nasdaq: SNDX) announced that the FDA has approved Revuforj® (revumenib) for treating relapsed or refractory acute leukemia with KMT2A translocation in adults and pediatric patients aged one and older. Approved based on positive results from the AUGMENT-101 trial, Revuforj is the first and only menin inhibitor for this indication. Syndax plans to launch the drug this month and will host a conference call today at 6:00 p.m. ET to discuss the approval.
Join Our Mailing List
Stay informed and supported. Join our mailing list today for the latest updates, resources, and community events delivered directly to your inbox.
Materials Spotlight
Testimonials
The MDS Foundation has been a great resource for our patients. We held a successful local symposium last year and hope to do that again in the future.
Afaf O
MDSF is fantastic so glad to have you there.
Amy D
We have enjoyed working with the MDS Foundation for many years.
Richard L
MDSF is a terrific organisation, and we appreciate the relationship.
Daniel P
I refer people regularly to the website and patient support services. The MDS Foundation is a great resource.
Mark J
I and my patients are huge fans of the MDS Foundation!
Yazan M
We are excited to keep working with the MDS Foundation as an MDS Center of Excellence to provide our patients the highest quality and state of the art care.
Aditi S
I believe that the Understanding Your MDS booklets and Building Blocks of Hope, MDS and AML Editions are invaluable resources, and I would love to be able to give them to my newly diagnosed patients.
Sophia B
My overall experience with the MDS Foundation is excellent.
Suresh D
I reviewed information on the MDS Foundation website in various languages, and it is very impressive.
Suresh D
It has been a tremendous blessing to have the MDS Foundation’s Northwestern team helping us through our MDS journey.
Stephen and Pat F
Center of excellence is like a 4 star Michelin restaurant rating.
Robert S
The MDS Foundation can assist you in getting into a center of excellence for MDS quickly. It is a top priority.
Amy C
I have found the forum to be a great help.
Marjory B
In my opinion everyone with MDS should put their trust in center of excellence.
Michael
